144 related articles for article (PubMed ID: 18164079)
1. Transcriptionally active PCR for antigen identification and vaccine development: in vitro genome-wide screening and in vivo immunogenicity.
Regis DP; Dobaño C; Quiñones-Olson P; Liang X; Graber NL; Stefaniak ME; Campo JJ; Carucci DJ; Roth DA; He H; Felgner PL; Doolan DL
Mol Biochem Parasitol; 2008 Mar; 158(1):32-45. PubMed ID: 18164079
[TBL] [Abstract][Full Text] [Related]
2. Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome.
Haddad D; Bilcikova E; Witney AA; Carlton JM; White CE; Blair PL; Chattopadhyay R; Russell J; Abot E; Charoenvit Y; Aguiar JC; Carucci DJ; Weiss WR
Infect Immun; 2004 Mar; 72(3):1594-602. PubMed ID: 14977966
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
[TBL] [Abstract][Full Text] [Related]
4. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
Sauzet JP; Perlaza BL; Brahimi K; Daubersies P; Druilhe P
Infect Immun; 2001 Feb; 69(2):1202-6. PubMed ID: 11160023
[TBL] [Abstract][Full Text] [Related]
5. Selection and identification of malaria vaccine target molecule using bioinformatics and DNA vaccination.
Shuaibu MN; Kikuchi M; Cherif MS; Helegbe GK; Yanagi T; Hirayama K
Vaccine; 2010 Oct; 28(42):6868-75. PubMed ID: 20709002
[TBL] [Abstract][Full Text] [Related]
6. Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use.
Hoffman SL; Doolan DL; Sedegah M; Aguiar JC; Wang R; Malik A; Gramzinski RA; Weiss WR; Hobart P; Norman JA; Margalith M; Hedstrom RC
Vaccine; 1997 Jun; 15(8):842-5. PubMed ID: 9234529
[TBL] [Abstract][Full Text] [Related]
7. T-cell recognition of a cross-reactive antigen(s) in erythrocyte stages of Plasmodium falciparum and Plasmodium yoelii: inhibition of parasitemia by this antigen(s).
Lucas B; Engels A; Camus D; Haque A
Infect Immun; 1993 Nov; 61(11):4863-9. PubMed ID: 8104901
[TBL] [Abstract][Full Text] [Related]
8. Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.
Narum DL; Kumar S; Rogers WO; Fuhrmann SR; Liang H; Oakley M; Taye A; Sim BK; Hoffman SL
Infect Immun; 2001 Dec; 69(12):7250-3. PubMed ID: 11705894
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle formulation enhanced protective immunity provoked by PYGPI8p-transamidase related protein (PyTAM) DNA vaccine in Plasmodium yoelii malaria model.
Cherif MS; Shuaibu MN; Kodama Y; Kurosaki T; Helegbe GK; Kikuchi M; Ichinose A; Yanagi T; Sasaki H; Yui K; Tien NH; Karbwang J; Hirayama K
Vaccine; 2014 Apr; 32(17):1998-2006. PubMed ID: 24440206
[TBL] [Abstract][Full Text] [Related]
11. Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein.
Speake C; Pichugin A; Sahu T; Malkov V; Morrison R; Pei Y; Juompan L; Milman N; Zarling S; Anderson C; Wong-Madden S; Wendler J; Ishizuka A; MacMillen ZW; Garcia V; Kappe SH; Krzych U; Duffy PE
PLoS One; 2016; 11(7):e0159449. PubMed ID: 27434123
[TBL] [Abstract][Full Text] [Related]
12. In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines.
Hedstrom RC; Doolan DL; Wang R; Kumar A; Sacci JB; Gardner MJ; Aguiar JC; Charoenvit Y; Sedegah M; Tine JA; Margalith M; Hobart P; Hoffman SL
Int J Mol Med; 1998 Jul; 2(1):29-38. PubMed ID: 9854139
[TBL] [Abstract][Full Text] [Related]
13. Vaxfectin enhances both antibody and in vitro T cell responses to each component of a 5-gene Plasmodium falciparum plasmid DNA vaccine mixture administered at low doses.
Sedegah M; Rogers WO; Belmonte M; Belmonte A; Banania G; Patterson NB; Rusalov D; Ferrari M; Richie TL; Doolan DL
Vaccine; 2010 Apr; 28(17):3055-65. PubMed ID: 19879998
[TBL] [Abstract][Full Text] [Related]
14. The development of a multivalent DNA vaccine for malaria.
Hedstrom RC; Doolan DL; Wang R; Gardner MJ; Kumar A; Sedegah M; Gramzinski RA; Sacci JB; Charoenvit Y; Weiss WR; Margalith M; Norman JA; Hobart P; Hoffman SL
Springer Semin Immunopathol; 1997; 19(2):147-59. PubMed ID: 9406343
[No Abstract] [Full Text] [Related]
15. Effect of nanoparticle coating on the immunogenicity of plasmid DNA vaccine encoding P. yoelii MSP-1 C-terminal.
Shuaibu MN; Cherif MS; Kurosaki T; Helegbe GK; Kikuchi M; Yanagi T; Sasaki H; Hirayama K
Vaccine; 2011 Apr; 29(17):3239-47. PubMed ID: 21354479
[TBL] [Abstract][Full Text] [Related]
16. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
Hoffman SL; Doolan DL
Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of recombinant BCG-based vaccine expressing the 22 kDa of serine repeat antigen (SE22) of Plasmodium falciparum.
Teo WH; Nurul AA; Norazmi MN
Trop Biomed; 2012 Jun; 29(2):239-53. PubMed ID: 22735846
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
[TBL] [Abstract][Full Text] [Related]
19. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
Dobaño C; Rogers WO; Gowda K; Doolan DL
Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation.
Dobaño C; Widera G; Rabussay D; Doolan DL
Vaccine; 2007 Sep; 25(36):6635-45. PubMed ID: 17669562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
